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Upon ligand binding, RIPK1 is recruited to tumor
necrosis factor receptor superfamily (TNFRSF) and
Toll-like receptor (TLR) complexespromotingprosur-
vival and inflammatory signaling. RIPK1 also directly
regulates caspase-8-mediated apoptosis or, if cas-
pase-8 activity is blocked, RIPK3-MLKL-dependent
necroptosis. We show that C57BL/6 Ripk1/ mice
die at birth of systemic inflammation that was not
transferable by the hematopoietic compartment.
However, Ripk1/ progenitors failed to engraft
lethally irradiated hosts properly. Blocking TNF
reversed this defect in emergency hematopoiesis
but, surprisingly, Tnfr1 deficiency did not prevent
inflammation in Ripk1/ neonates. Deletion of
Ripk3 orMlkl, but not Casp8, prevented extracellular
release of the necroptotic DAMP, IL-33, and reduced
Myd88-dependent inflammation.Reduced inflamma-
tion in the Ripk1/Ripk3/, Ripk1/Mlkl/, and
Ripk1/Myd88/miceprevented neonatal lethality,
but only Ripk1/Ripk3/Casp8/ mice survived
past weaning. These results reveal a key function
for RIPK1 in inhibiting necroptosis and, thereby, a
role in limiting, not only promoting, inflammation.
INTRODUCTION
Befitting its major inflammatory role, tumor necrosis factor (TNF)
signaling via its receptor TNFR1 is highly regulated. In addition todriving the transcription of a host of inflammatory cytokines, TNF
is also capable of initiating two cell death pathways, caspase-8-
dependent apoptosis and RIPK1 kinase-dependent necroptosis
(Vandenabeele et al., 2010). However, in the vast majority of
cells, TNF does not induce cell death. It is believed that this is
because the same IkB kinase (IKK)/mitogen-activated protein
kinase (MAPK)-dependent increase in transcription that drives
inflammatory cytokine production also upregulates antiapop-
totic genes that inhibit the activation of caspase-8. Cellular
FLICE-like inhibitory protein (cFLIP), a caspase-8 inhibitor, is
chief among these antiapoptotic genes, and in the absence of
cFLIP, TNF rapidly induces caspase-8-dependent apoptosis
(Panayotova-Dimitrova et al., 2013; Piao et al., 2012). RIPK1 is
believed to play an essential role in the activation of IKK/MAPK
and in the transcription of cFLIP (Ea et al., 2006; Gentle et al.,
2011; Micheau et al., 2001). In this role, it behaves as a structural
element that is ubiquitylated by cellular inhibitor of apoptosis
proteins (cIAPs) and linear ubiquitin chain assembly complex
(LUBAC), and the ubiquitin chains decorating RIPK1 can recruit
and trigger the activation of NF-kB and MAP kinases (Schmukle
and Walczak, 2012; Wertz and Dixit, 2010). Consistent with an
essential role for cFLIP in regulating caspase-8, cFlip/Cflar
knockout mice die at embryonic stage E10.5 (Yeh et al., 2000).
Activation of caspase-8 by TNF occurs in a secondary cyto-
plasmic signaling complex that contains the protein Fas-associ-
ated protein with death domain (FADD) (Micheau and Tschopp,
2003). The death effector domain of FADD causes the oligomer-
ization and autoactivation of caspase-8 (Wertz andDixit, 2010). It
is therefore surprising that Fadd and Casp8 knockout mice both
die at the same embryonic stage, from the same defects, as the
cFlip/Cflar-deficient mice (Varfolomeev et al., 1998; Yeh et al.,
1998). Because Fadd/Ripk3/ and Casp8/Ripk3/ miceCell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc. 1175
survive to adulthood (Kaiser et al., 2011; Oberst et al., 2011; Dil-
lon et al., 2012), it is supposed that, in the absence of cFLIP, a
lethal apoptotic pathway is initiated and that, in the absence of
caspase-8 activation, an alternative lethal necroptotic RIPK1/
RIPK3-dependent pathway occurs.
Therefore, current models for TNF signaling indicate that
RIPK1 plays very important roles in two branches of the
TNFR1 response: to inhibit apoptosis via cFLIP and to cause
necroptosis in a RIPK1-kinase-dependent manner (Vandena-
beele et al., 2010). Furthermore, RIPK1 may play similar roles
in other innate immune signaling complexes, including Toll-like
receptor (TLR) and MAVS/RIG-I (Kaiser et al., 2013; Meylan
et al., 2004; Michallet et al., 2008). The pivotal role for RIPK1 in
regulating outcomes from these innate immune signaling com-
plexes makes the phenotype of the Ripk1/ mice remarkable.
In distinction to other regulators of the TNF pathway that die at
embryonic stage E10.5, Ripk1/ mice on a mixed 129/Sv
C57BL/6 background die within 3 days of birth (Kelliher et al.,
1998). However, survival of the Ripk1/ mice was prolonged
to 12 days after birth by Tnfr1 deletion (Cusson et al., 2002).
Although Tnfr1 deletion provides protection from Ripk1/
perinatal lethality, it is incomplete, and the reason for the death
of Ripk1/ mice remains enigmatic. We therefore sought to
determine the cause of this lethality. We show that, on a
C57BL/6 background, Ripk1/ mice die at birth from systemic
inflammation, but they can be partially protected by deleting
Myd88 and thereby blocking IL-1 family and TLR inflammatory
signaling. Furthermore, the embryonic lethality of Casp8/
mice can be prevented by loss of RIPK1; however, loss of cas-
pase-8 cannot protect Ripk1/ mice from systemic inflamma-
tion and perinatal death. On the other hand, loss of the essential
effectors of necroptosis, RIPK3 or MLKL, provides protection to
Ripk1/ mice from systemic inflammation but fails to correct a
lethal intestinal defect. Ripk1 deficiency-induced inflammation
was associated with the release of IL-33, suggesting that this
cytokine is a necroptotic danger-associated molecular pattern
(DAMP) in vivo. Finally, we show that Ripk1/Ripk3/
Casp8/ mice were protected from inflammation and intestinal
disruption and are viable and fertile. These results add to our
understanding of the role of RIPK1 in regulating cell-death-
inflammatory signaling pathways and demonstrate that necrop-
totic cell death can initiate a lethal inflammatory cascade.
RESULTS
RIPK1 Deficiency Results in Perinatal Lethality Marked
by Systemic Cell Death
Ripk1/ mice die within 3 days of birth on a mixed 129/Sv
C57BL/6 background (Kelliher et al., 1998). After more than ten
crosses with C57BL/6 mice, we found that Ripk1/ mice
develop severe multiorgan inflammation in utero and die within
minutes of birth or Caesarean section. Ripk1/ neonates
appeared edematous and cyanotic (Figure 1A). The rapid
cyanosis ofRipk1/ neonates and labored breathing (Figure 1B)
suggests that respiratory failure is the major cause of perinatal
lethality. Cell death was the most striking histopathological
finding with large necrotic regions in the liver and thymus (Fig-
ure 1C and Figure S1 and Table S2 available online) and cleaved1176 Cell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc.caspase-3 (CC3)-positive cells in lung, liver, intestine, and
thymus (Figures 1D and S1). CC3 and -8 were also detectable
in plasma from Ripk1/, but not Ripk1+/+ neonates (Figure 1E).
Ripk1/ neonates had epidermal hyperplasia with no signs of
CC3 (Figures 1C and 1D). Keratin-6 expression, which is nor-
mally confined to hair follicles in healthy skin, was also aberrantly
expressed in Ripk1/ epidermis (Figure 1C).
Ripk1/ Neonates Exhibit Systemic Inflammation
Inflammatory cytokines were upregulated in the skin (Figure 2A),
plasma (Figure 2B), liver, lung, and intestine (Figure S2A).
Ripk1/ neonates also had severe anemia and neutrophilia
(Figures 2C–2E, S2B, and S2C), which is consistent with the
elevated levels of proinflammatory cytokines and chemokines
in the plasma; granulocyte colony-stimulating factor (G-CSF)
was elevated >105-fold (Figures 2B and S2A). Surprisingly, given
these results, the number of leukocytes in various tissues was
reduced (Figures 2F and S1).
RIPK1 Is Required for Normal Hematopoiesis
To assess whether the inflammatory Ripk1/ phenotype was
transferable, we transplanted lethally irradiated mice with wild-
type (WT) or Ripk1/ fetal liver cells taken at embryonic day (E)
13.5. There was no evidence of inflammatory disease in recipient
mice (Figure S3A); however, Ripk1/ hematopoietic cells failed
to engraft efficiently, with deficits in both myeloid and lymphoid
lineages evident 8 weeks posttransplant (Figures 3A and 3B).
Furthermore, at 14 and 26 weeks, an almost-complete loss of
myeloid and lymphoid donor Ripk1/ cells was observed (Fig-
ure 3A). Embryonic WT progenitor cells express RIPK1 (Fig-
ure S3B), and Ripk1/ embryos had a normal hematopoietic
progenitor cell compartment at E13.5 but a decrease in granulo-
cyte-macrophage progenitors and megakaryocyte-erythroid
progenitors at P0 (Figure 3C). Furthermore, the functional
potential of Ripk1/ embryonic progenitors remained normal
ex vivo (Figure 3D). This suggests that the deficits observed in
Ripk1/ hematopoietic progenitor cells at P0 are a reflection
of the systemic inflammation in these mice, but this does not
account for the deficit when fetal liver cells are used to reconsti-
tute mice (Figure 3C). Competitive transplantation of Ripk1/
and WT fetal liver cells at a 1:1 ratio into lethally irradiated recip-
ient mice revealed that WT cells outcompeted Ripk1/ cells
(Figure 3E), suggesting a cell-intrinsic defect in Ripk1/
hematopoietic stem and progenitor cells (HSPC). Furthermore,
lethally irradiated recipient mice receiving a serial transplant of
either 0.23106 or 13106Ripk1/bonemarrow (BM) cells failed
to thrive and succumbed to BM failure within 3weeks (Figure 3F).
These results demonstrate that Ripk1/ HSPC are defective in
their ability to self-renew. Mice transplanted with 5 3 106
Ripk1/ BM cells survived similarly to mice receiving 0.2 3 106
WT cells, indicating that an increase in Ripk1/ donor cells can
partially compensate for this cell-intrinsic defect (Figure 3G).
TNF Neutralization Rescues the Ripk1/ Emergency
Hematopoiesis Defect
Because RIPK1 regulates TNF signaling and TNFR1 is upregu-
lated in donor and recipient-derived hematopoietic cells in the
bone marrow following transplantation (Pearl-Yafe et al., 2010;
Figure 1. Ripk1/ Neonates Die at Birth and Exhibit Multiorgan Pathology
(A) Neonates of indicated genotypes.
(B) Respiratory rates of neonates taken within minutes of Caesarean, nR 3, columns show mean + SEM, ***p% 0.005.
(C) Tissue sections of Ripk1+/+ and Ripk1/ mice stained with H&E, anti-keratin-6, or anti-keratin-14 (Red). Nuclei in immunofluorescence sections were
counterstained with Hoechst (blue). N, necrotic and V, viable regions of liver. Red arrows, luminal slough. Each image is representative of at least three mice.
(D) Tissue sections stainedwith anti-CC3 (brown) and hematoxylin (blue). Black arrows, cleaved-caspase-3-positive cells. Each image is representative of at least
three mice.
(E) Western blot of plasma from P0mice of each genotype, n = 3, probed for cleaved caspase-3 (CC3) and cleaved caspase-8 (CC8), Ponceau S loading control.
All data were obtained from neonates delivered by Caesarean at P0. All scale bars, 50 mm.Weill et al., 1996), we hypothesized that deregulated TNF-TNFR1
signaling may cause the Ripk1/ engraftment defect. We there-
fore investigated whether TNF or other death ligands mediated
this defect. Indeed, Ripk1/ progenitors were more sensitive
to TNF and FasL as determined by their short-term survival (Fig-
ure S3C). Similarly, the yield of macrophages derived from
Ripk1/ fetal liver was reduced (Figure S3D), and theywere sen-
sitive toTNF-inducedcell death (FigureS3E). Finally,we repeated
the engraftment experiments with a TNF blocking antibody that
rescued the reconstitution defect (Figure 3H). These reconsti-
tuted mice did not show signs of inflammation. Together, these
results suggest that loss of RIPK1 sensitizes hematopoietic cells,
including progenitors, to TNF-induced cell death, but this intrinsic
defect, in isolation, is insufficient to initiate inflammatory disease.
Loss of TNFR1, FasL, or Caspase-8 Does Not Prevent
Ripk1/ Lethality
To examine the contribution of apoptotic signaling to Ripk1/
neonatal lethality, we generated Ripk1/Tnfr1/ mice. In
contrast to the partial suppression previously observed withTnfr1 deletion on the mixed 129/Sv background (Cusson et al.,
2002), loss of Tnfr1 did not provide meaningful protection on
the C57BL/6 background, and Ripk1/Tnfr1/ neonates died
within half an hour of birth (Figure 4A). Combined deficiency of
TNF and the cell death ligand, FasL, also failed to prevent the
Ripk1/ lethality (Figures 4A and 4B).
To test the direct contribution of the extrinsic apoptotic
pathway to the Ripk1/ phenotype, we generated Ripk1/
Casp8/ mice. Despite the fact that loss of caspase-8 results
in lethality at E10.5 (Varfolomeev et al., 1998), these mice sur-
vived to birth. However, Ripk1/Casp8/ neonates were indis-
tinguishable from their littermate Ripk1/ controls and died
minutes after birth (Figure 4A). Ripk1/Casp8/ and Ripk1/
Tnfr1/ mice had the elevated white blood cell count, anemia,
and inflammation seen in Ripk1/ neonates (Figures 4B, 4C,
S4A, and S4B). Likewise, Ripk1/Casp8/ and Ripk1/
Tnfr1/ mice still had CC3 present in the plasma, as well as
epidermal hyperplasia and aberrant keratin-6 expression (Fig-
ures 4D, 4E, and S4C). On the other hand, the large intestinal
phenotype in Ripk1/ mice was partially and completelyCell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc. 1177
Figure 2. RIPK1 Is Required to Inhibit Sys-
temic Inflammation, Anemia, and Neutro-
philia
(A and B) Skin, n = 3 (A) and plasma, n = 5 (B)
cytokine levels assayed using Bioplex. Number
symbol (#), four of five values for plasma G-CSF
were above the reference range and assigned
value of highest standard. Controls, Ripk1+/+ or
Ripk1+/.
(C) Blood cells quantified with an ADVIA, n R 4.
WBC, white blood cells; RBC, red blood cells.
(D) Flow cytometric analysis of CD11b+ peripheral
blood cells, Ly6G+ly6Cint, neutrophils; Ly6Chi,
inflammatory monocytes; Ly6Clow, resident
monocytes.
(E) Differential counts obtained from blood
smears, n R 4. PM, polymorphs; Lymph, lym-
phocytes; Mon, monocytes.
(F) Tissue sections stained with anti-F4/80 or anti-
CD45. Each image is representative of at least
three mice. Data were obtained from neonates
delivered byCaesarean at E20.5 (A) or E19.5 (B–F).
All graphs show mean values + SEM, *p % 0.05,
**p% 0.01, and ***p% 0.005. All scale bars, 50 mm.suppressed in Ripk1/Tnfr1/ and the Ripk1/Casp8/
neonates, respectively, and correlated with the lack of CC3 in
the intestine (Figures 4F and S4C).
RIPK3 andMLKLDeficiencyPreventsRipk1/Systemic
Inflammation
According to prevailing models, loss of RIPK1 should block nec-
roptosis. However, the fact that loss of Casp8, and therefore
apoptosis, did not protect Ripk1/ mice from perinatal lethality
caused us to re-examine this. We therefore hypothesized that
excessive necroptotic cell death occurs in Ripk1/ neonates
and generated Ripk1/Ripk3/ and Ripk1/Mlkl/ mice to
test this. Remarkably, these mice appeared normal at birth (Fig-
ure 5A). Cell death that was visible by hematoxylin and eosin
staining (H&E) was also reduced in these mice, and CC3 was
undetectable in their plasma and reduced in all organs except
the intestine (Figures 5B, 5C, and S5F). Consistent with necrop-
totic cell death driving inflammation, Ripk1/Ripk3/ and
Ripk1/Mlkl/ mice mostly had normal keratin-6 and -14
expression (Figures 5D and S5G and Table S3) and normal
white and red blood cell levels at P0 and P3 (Figures 5E and
S5B), and leukocyte levels in tissues were restored (Figure S5F).
These mice also had reduced inflammatory cytokine levels at
these time points (Figures 5F and S5D) compared to the1178 Cell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc.Ripk1/ mice. Nevertheless, Ripk1/
Ripk3/ and Ripk1/Mlkl/mice failed
to thrive, had hypoglycemia (Figures 5A,
5G, and S5A) despite being fed, and did
not survive past postnatal day 4 (P4).
CompoundRipk3 deficiency also partially
suppressed the defect of Ripk1/ he-
matopoietic cells at 8 weeks posttrans-
plant in primary and serial transplant
recipient mice (Figures 5H and S5E).We sought to correlate these changes with molecular markers
of apoptosis and necroptosis. Remarkably, RIPK3, MLKL, and
cFLIP levels were all elevated in Ripk1/ skin when compared
to WT controls (Figures 5I and 5J). This elevated cFLIP could
inhibit caspase-8-induced apoptosis and, together, with the
elevated levels of the necroptotic effectors, provides a potential
explanation for the suppression of Ripk1/ keratinocyte hyper-
plasia by combined loss of MLKL or RIPK3.
Ripk1/ Systemic Inflammation Is Not Driven by the
Inflammasome
Because pyroptosis, a caspase-1-dependent cell death, can
result in systemic inflammation and was suggested to be de-
pendent on RIPK3 in BMDM and BMDC models, we tested the
possibility that the inflammasome is activated in Ripk1/
mice. Lipopolysaccharide (LPS) priming in Ripk1/ fetal liver-
derived macrophages (FLDM), without an inflammasome stim-
ulus, resulted in secretion of low levels of cleaved IL-1b and
caspase-1 (Figures 6A and S6A). In agreement with earlier re-
ports (Kang et al., 2013; Vince et al., 2012), this active inflamma-
some status in Ripk1/ FLDM was RIPK3 dependent (Figures
6A and S6A). In vitro, this indicates that Ripk1/ macrophages
have constitutive low-level inflammasome activity. In vivo, how-
ever, we could not detect signs of inflammasome activation—on
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Figure 3. RIPK1 Is Required for Normal
Hematopoiesis
(A) Contribution of donor and recipient cells in
the bone marrow and spleen of lethally irradiated
recipients 8, 14, and 26 weeks posttransplant, n =
3–7.
(B) Counts of hematopoietic stem cells (HSC),
lineage-restricted progenitors (LRP), multi-
potent progenitors (MPP), common myeloid
progenitors (CMP), granulocyte-macrophage pro-
genitors (GMP), megakaryocyte-erythroid pro-
genitors (MEP), and common lymphoidprogenitors
(CLP) from the bone marrow of lethally irradiated
recipients 8 weeks posttransplant, n = 3–7.
(C) Counts of Ripk1+/+ and Ripk1/ liver pro-
genitors at E13.5 and P0, n R 4.
(D) Differentiation of E13.5 and E18.5 fetal liver
progenitors after 7 days of culture in SCF+IL-
3+EPO. Granulocyte (G), macrophage (M), gran-
ulocyte-macrophage (GM), and megakaryocyte
(Meg) colonies, n = 3–7.
(E) Contribution of Ripk1+/+ and Ripk1/ cells in
bone marrow and spleen of lethally irradiated
recipients transplanted with equal numbers of
Ripk1+/+ and Ripk1/ fetal liver cells 8 weeks
posttransplant, n = 5.
(F) Survival of serial transplant recipients, trans-
planted with 0.23 106–53 106 bone marrow cells
from Ripk1+/+ or Ripk1/ reconstituted mice, n =
5–8.
(G) Contribution of donor and recipient blood cells
in serial transplant recipients from (F) 8 weeks
posttransplant.
(H) Analysis of bone marrow from reconstituted
mice at 8 weeks. Where indicated, recipient mice
were treatedwithTNF-blocking antibodyor isotype
control (Iso) three times per week for 2 weeks then
weekly for 6 weeks, n = 6 mice per group. Neut,
neutrophil; I. Mon, inflammatory monocyte; R.
Mon, resident monocyte; LSK, LinSca-1+c-Kit+.
All graphs showmean + SEM; *p% 0.05 and **p%
0.01.the contrary, caspase-1 and IL-1b were present in the pro, un-
cleaved form in tissue and plasma (Figures 6B–6D). Thus, we
conclude that the inflammasome plays little to no role in
Ripk1/ neonatal systemic inflammation.
The Necroptotic DAMPs, IL-1a and IL-33, Correlate with
Ripk1/ Inflammation
Several DAMPs, including HMGB1, IL-1a, and IL-33, have been
suggested to be released from necroptotic cells. The relativeCell 157, 1175–11importance of these DAMPs in vivo is
unknown (Kaczmarek et al., 2013).
HMGB1 levels in the plasma of Ripk1/
and WT neonates were identical (Fig-
ure 6E). On the other hand, there were
high levels of IL-1a and IL-33 in the
plasma of Ripk1/ neonates (Figures 6F
and 6G). Furthermore, IL-33 expression
was elevated in the skin and intestine ofRipk1/ neonates and was released as a processed and inflam-
matory form (Lefranc¸ais et al., 2012) in the plasma of Ripk1/
and Ripk1/Casp8/ mice, but not in Ripk1/Mlkl/ or
Ripk1/Ripk3/ mice, indicating an important role for necrop-
totic death in IL-33 production (Figure 6G).
MyD88 Deficiency Suppresses Ripk1/ Inflammation
MyD88 is an essential component of IL-1, IL-33, and a subset of
TLR signaling complexes (Beutler et al., 2006). We therefore88, May 22, 2014 ª2014 Elsevier Inc. 1179
Figure 4. Tnfr1 and Casp8 Deficiency Pro-
vides No Survival Advantage to Ripk1/
Neonates but Ameliorates the Large Intes-
tine Phenotype
(A) Neonates of indicated genotype obtained after
Caesarean delivery at P0.
(B) Blood cell quantification using an ADVIA, n R
3. WBC, white blood cells; RBC, red blood
cells. Tnfr1 control, Ripk1+/+Tnfr1/. TnfFasl
control, Ripk1+/ Tnf/Faslgld/gld. Casp8 control,
Ripk1+/+ or +/ Casp8+/+ or +/.
(C) Plasma cytokine levels of P0 mice assayed
using Bioplex, n = 4.
(D) Western blot of plasma from three Ripk1/
Tnfr1/ and two Ripk1/Casp8/ mice probed
for cleaved caspase-3 (CC3). Ponceau S loading
control. Asterisk (*) indicates nonspecific band.
(E) Immunofluorescence analysis of skin sections
stained with anti-keratin-6, anti-keratin-14 (red), or
Hoechst nuclear stain (blue).
(F) Tissue sections stained with anti-CC3 (brown)
and hematoxylin (blue).
(E and F) Each image is representative of at least
three mice. Control, WT.
All graphs are mean + SEM. *p% 0.05, **p% 0.01,
and ***p% 0.005.hypothesized that Myd88 deficiency could provide a survival
advantage to Ripk1/ mice by reducing these inflammatory
pathways. In contrast to the lack of suppression of the Ripk1/
phenotype observed with Tnfr1 deletion, Ripk1/Myd88/ ne-
onates appeared relatively normal at birth and had mild to no
edema (Figure 6H). Unfortunately, like the Ripk3/ and Mlkl/
crosses, the mice failed to thrive and only survived about
4 days from birth (Figure S6B). Deletion of Myd88 reduced neu-
trophilia, prevented the anemia, and dramatically reduced the
inflammation seen in Ripk1/ neonates (Figures 6I, 6J, S6C,
and S6D). At P0, epidermal hyperplasia and CC3 in the plasma
were still observed in Ripk1/Myd88/ neonates (Figures 6K
and S6F and Table S1). Nevertheless, in surviving mice (P3),
Myd88 loss prevented the epidermal hyperplasia, but not the
intestinal CC3 and the low blood glucose seen in Ripk1/
neonates (Figures 6L, 6M, S6E, and S6F).1180 Cell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc.Caspase-8 Deficiency Prevents
Ripk1/Ripk3/ Lethality
The areas of enterocyte cell death and
CC3-positive cells in Ripk1/Ripk3/,
Ripk1/Mlkl/, and Ripk1/Myd88/
mice, which progressively worsen from
birth to P3, raised the possibility that
defective gastrointestinal function may
be the underlying cause of death in these
compound knockout mice. One obvious
possibility was that bacterial colonization
after birth leads to TNF production and
intestinal cell death; however, Ripk1/
Ripk3/ mice generated in an abiotic
environment were not protected from
early death (Table S1).To test whether the loss of gastrointestinal function was the
result of excessive caspase-8-dependent apoptosis in the
Ripk1/Ripk3/ and Ripk1/Mlkl/ mice, as suggested by
the prevention of the intestinal pathology in the Ripk1/
Casp8/ mice, we generated Ripk1/Ripk3/Casp8/
mice. These mice were viable and fertile and put on weight like
their WT counterparts (Figures 7A and S7A). CC3 was absent
from the intestine and plasma, and the mice displayed none of
the Ripk1/ inflammatory pathology (Figures 7B, 7C, S7B,
S7C, and S7F–S7I and Table S3). Furthermore, unlike Ripk1/
fetal liver cells, Ripk1/Ripk3/Casp8/ cells were not out-
competed byWT cells in a competitive transplant assay (Figures
7D and S7J). When aged, these mice developed the lympho-
proliferative syndrome (Figures 7E–7G, S7D, and S7E) seen in
Casp8/Ripk3/ mice (Kaiser et al., 2011; Oberst et al.,
2011). However, the severity of this disease was attenuated in
Figure 5. Ripk1/ Lethality Is Partly Medi-
ated by RIPK3 and MLKL
(A) Ripk1/Ripk3/ and Ripk1/Mlkl/ mice
and littermate controls at P0, P3, or P4.
(B) Western blot of plasma from three P0 mice of
each genotype probed for CC3. Ponceau S
loading control.
(C) Tissue sections of P0 or P3 mice stained with
anti-CC3 (brown) and hematoxylin (blue).
(D) Skin sections from indicated genotype stained
with anti-keratin-6 or anti-keratin-14 (red) coun-
terstained with Hoechst (blue). Ripk1/ images in
(D) are duplicated from Figure 1 for purposes of
reference.
(C and D) Each image is representative of at least
three mice. Control, Ripk1+/+ or +/Ripk3/.
(E) Blood cells from P0 mice quantified using
ADVIA, n R 3. WBC, white blood cells; RBC, red
blood cells.
(F) Plasma cytokine levels of P0 or P3 mice as-
sayed using Bioplex, nR 3. Control,Ripk1+/+ or +/
Ripk3/.
(G) Blood glucose levels from P3 mice quantified
using an Accu-Chek glucometer; Ripk3 control,
Ripk1+/+ or +/ Ripk3/, n = 32; Ripk1/Ripk3/,
n = 11; Mlkl control; Ripk1+/+ or +/ Mlkl +/ or /,
n = 8; Ripk1/Mlkl/, n = 4.
(H) Blood cell counts from bone marrow of WT
recipient mice transplanted with 13 106 fetal liver
cells of the indicated genotypes and then serially
transplanted with 5 3 106 BM cells. Analysis was
performed 8 weeks posttransplant using flow
cytometry. Neut, neutrophil; I. Mon, inflammatory
monocyte; LSK, LinSca-1+c-Kit+.
(I and J) Western blot of tissue lysates probed
with the indicated antibodies. Ripk1/, n = 4;
Ripk1+/+ or +/, n = 4. The asterisk (*) indicates a
nonspecific band.
All graphs depict mean + SEM. *p % 0.05 and
***p% 0.005.a Ripk1 dose-dependent manner, such that splenomegaly was
almost abolished in the Ripk1/Ripk3/Casp8/ mice and
reduced in the Ripk1 heterozygotes at 16–18 weeks (Figures
7E and 7F). Likewise, infiltration of CD3+B220+ cells into periph-
eral organs was reduced by loss of Ripk1 (Figure 7G).
DISCUSSION
We show that C57BL/6 Ripk1/ neonates succumb to a cell-
death-induced inflammatory phenotype with multiorgan pa-
thology (Table S1). Ripk1/ mice on a mixed 129/Sv C57BL/6
background died within 3 days of birth (P3) (Kelliher et al.,
1998), but by the fourth backcross of mixed backgroundCell 157, 1175–11Ripk1/ to C57BL/6 mice, we were
unable to recover viable knockout mice
at P0. The 129/Sv strain is mutant for
caspase-11, and some of the phenotype
previously ascribed to loss of caspase-
1, a closely linked gene in the same
9qA1 chromosomal location, is due tothe loss of caspase-11 (Kayagaki et al., 2011). However, RIPK1
is on murine chromosome 13, and therefore, given the extent
of the backcross needed to reveal the perinatal lethality, func-
tional caspase-11 is unlikely to be the modifier. The importance
of the genetic background is emphasized by the role of Tnfr1 in
the Ripk1/ phenotype. C57BL/6 129/Sv Ripk1/Tnfr1/
mice survive up to 12 days after birth (Cusson et al., 2002).
Remarkably, however, given the focus on the role of RIPK1 in
TNF signaling, Ripk1/ lethality at birth was not prevented at
all by deletion of Tnfr1 on a C57BL/6 background, although the
disrupted intestinal phenotype was.
Cusson et al. (2002) reported that Ripk1/ thymocytes were
reduced 6 weeks after transplant of Ripk1/ fetal liver cells88, May 22, 2014 ª2014 Elsevier Inc. 1181
(legend on next page)
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into lethally irradiated mice and died in a TNFR2-dependent
manner, but B and myeloid cell numbers appeared normal. We
found that B- and T-lymphoid and neutrophil numbers were
reduced 8 weeks posttransplant in the absence of RIPK1.
Furthermore, at this time, there were deficits in progenitor cell
numbers, and, by 14 weeks, profound defects in the ability of
Ripk1/ cells to reconstitute all hematopoietic compartments
became apparent. During engraftment, a model of emergency
hematopoiesis, hematopoietic stem cells must rapidly generate
large numbers of mature cells for the recipient to survive. Our
results demonstrate that TNF, which was shown to be upregu-
lated during emergency hematopoiesis (Weill et al., 1996), plays
a role in theRipk1/ engraftment defect because administration
of neutralizing TNF antibodies suppressed the emergency
hematopoietic defect. Similarly, loss of caspase-8 also causes
B, T, and progenitor cell defects in Rag1/ reconstituted mice
(Kang et al., 2004). Together, with our result that compound defi-
ciency of Ripk3 partially prevented the reconstitution defects
seen in Ripk1/ hematopoietic cells, this suggests that both
apoptotic and necroptotic pathways are activated by TNF in
Ripk1/ hematopoietic cells during engraftment. Consistent
with this, we observed that Ripk1/Ripk3/Casp8/ fetal liver
cells were able to compete with WT cells in a competitive trans-
plant. These results demonstrate that there are TNF-dependent
roles for RIPK1 in stress-induced hematopoiesis and that TNF
appears to license hematopoietic stem and progenitor cells
entering the bone marrow during inflammation by delivering a
RIPK1-dependent survival signal. These experiments also
showed that Ripk1/ cells do not transfer the inflammatory
phenotype into WT recipients. One caveat to this conclusion is
that Ripk1/ fetal liver cells do not reconstitute properly. How-
ever, at 8 weeks posttransplant, there appear to be sufficient
numbers of Ripk1/ neutrophils and monocytes to drive inflam-
matory disease. Furthermore, Ripk1/ reconstitutions treated
with anti-TNF successfully engrafted but failed to transfer the
inflammatory phenotype. Because TNF plays little to no role in
the systemic inflammation in Ripk1/ mice, it seems unlikely
that the hematopoietic compartment, in isolation, is a major initi-
ator of the inflammatory phenotype.
Despite the fact that TNF/TNFR1 signaling does not play a
significant role in Ripk1/ lethality, RIPK1 clearly has a protec-Figure 6. Ripk1/ Inflammatory Phenotype Is Myd88 Dependent and
(A) IL-1b secretion from E13.5 FLDMs, primed with ultrapure LPS (20 ng/ml) for 6
(B and C) Western blot of skin and intestine tissue lysates probed with anti-caspa
from BMDMs treated with LPS ± Smac mimetic (SM) were used as controls for c
(D–F) Western blot of plasma from P0 mice probed with caspase-1 and IL-1b (D)
Ponceau S loading control. Asterisk (*) indicates nonspecific band. Lysates from
cleavage (D). HMGB1-positive control is lysate from BMDMs (E).
(G) Western blot of plasma (top) and tissue (bottom) from P0 neonates with anti-
Mlkl/, Ripk3/ or WT for Ripk1/. Asterisk (*) indicates nonspecific band.
(H) Neonates of indicated genotype obtained after Caesarean at P0 or P3.
(I) Blood cell quantification using ADVIA, nR 3. WBC, white blood cells; RBC, re
(J) Plasma cytokine levels of P0 mice assayed using Bioplex, nR 3.
(K) Western blot of plasma from P0 mice; n = 3 of each genotype probed for CC
(L) Skin sections stained with anti-keratin-6 or anti-keratin-14 (red) and Hoechst
(M) Tissue sections of P0 or P3 mice stained with anti-CC3 (brown) and hematox
(L and M) Each image is representative of at least three mice. Control, Myd88/
All graphs show mean + SEM. ***p% 0.005. All scale bars, 50 mm.tive role in TNF signaling. In this role, it provides a platform
for recruitment of kinases that are required to activate NF-kB
and thereby upregulate antiapoptotic proteins, principally cFLIP,
to prevent activation of caspase-8 and -3 and apoptosis
(Schmukle and Walczak, 2012; Wertz and Dixit, 2010). The
power of genetic experiments is that they test such models in
global terms. Loss of RIPK1 in the mouse leads to massive cell
death, associated with CC3 and -8; therefore, RIPK1 clearly
plays a protective role during embryogenesis. However, there
are important exceptions; for example, a TNF-dependent check-
point exists at embryonic stage E10.5 (Dillon et al., 2014 [this
issue ofCell]), and in the absence of cFLIP, mice die at this stage
(Yeh et al., 2000). Because loss of RIPK1 does not lead to embry-
onic death at E10.5, then RIPK1 is not required to protect against
TNF-driven lethality at E10.5. Furthermore, we can conclude that
production of cFLIP at E10.5 is independent of RIPK1. More
surprisingly still, loss of RIPK1 results in dramatic upregulation
of cFLIP levels in the skin, turning the accepted model on its
head in this tissue.
In other tissues, the cFLIP/RIPK1 axis may play a more im-
portant role. Conditional deletion of cFlip in intestinal epithelial
cells (Piao et al., 2012) led to uncontrolled apoptosis and peri-
natal lethality (P2), which was prevented by deletion of Tnfr1.
Although Tnfr1 deletion did not prevent early lethality of
Ripk1/ mice, we observed reduction in cell death and pathol-
ogy in the large intestine. Thus, the TNF/TNFR1/RIPK1 signaling
axis plays an important role in the intestine, but the source of TNF
is unknown. TNF/TNFR1 knockout mice have defective Peyer’s
patch formation (Korner et al., 1997), thus there might be a local,
developmentally regulated source of TNF. Alternatively, the
intestine of P0 Ripk1/ mice may be exquisitely sensitive to
systemic TNF circulating in these mice. Ripk1/Myd88/,
Ripk1/Ripk3/, and Ripk1/Mlkl/ mice survive beyond
birth and become colonized by bacteria. Thus, in these mice, it
is possible that host-microbial interactions generate TNF. How-
ever, Ripk1/Ripk3/ mice raised in an abiotic environment
had no survival advantage, indicating that host-microbiome
interaction is not a significant factor in the lethality at P4. Similarly
to Tnfr1 deletion, Casp8 deletion reduced cell death and pathol-
ogy in the large intestine of Ripk1/ mice. In agreement with
our interpretation that the excessive intestinal apoptosis killsIs Marked by the Presence of Cleaved IL-33 in the Plasma
–8 hr ± 5 mM ATP for 60 min were analyzed by ELISA, nR 4.
se-1 (B) and anti-IL-1b (C), Ripk1/, n = 3; Ripk1+/+ or +/, n = 3. Supernatant
aspase-1 cleavage (B).
, HMGB1 (E), and IL-1a (F) antibodies; Ripk1/, nR 3; Ripk1+/+ or +/, nR 3.
BMDMs treated as per (A) were used as controls for caspase-1 and IL-1b
IL-33. Skin and intestine controls, Ripk1+/+ or Ripk1+/ mice; plasma controls,
d blood cells.
3. Run on same gel as Figure 4D.
(blue).
ylin (blue).
.
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Figure 7. Ripk1/Ripk3/ Lethality Is
Mediated by Caspase-8
(A) Ripk1/Ripk3/Casp8/ and control
Ripk+/ Ripk3/Casp8+/+ mice at 16 weeks.
(B) Tissue sections from P3mice stained with anti-
CC3. Each image is representative of three mice.
(C) Western blot of plasma from 17- to 18-week-
old mice probed for CC3. Ponceau S loading
control. Plasma from the P0 Ripk1/ control
was run on the same gel.
(D) Percentage contribution of recipient BM cells
from lethally irradiated mice injected with a 1:1
ratio of fetal liver cells from indicated genotypes.
Neut, neutrophil; I. Mon, inflammatory monocyte;
LSK, LinSca-1+c-Kit+; n = 3 mice per group.
(E) Lymph nodes (LN), spleen, and thymus of 18-
week-old mice of the indicated genotypes.
(F) Spleen weights of 16- to 18-week-old mice of
the indicated genotypes.
(G) Percentage of CD3+B220+ cells in the spleen,
peripheral blood (PB), BM, and LN of 16- to 18-
week-old mice.
All graphs show mean + SEM. *p% 0.05. All scale
bars, 50 mm.Ripk1/Ripk3/ mice at P4, Ripk1/Ripk3/Casp8/ mice
survived to adulthood.
RIPK1 not only protects from TNF induced killing, but if
caspase-8 activity is inhibited, then it is believed to be required
for TNF- or TLR-induced necroptosis in a kinase-dependent
manner. In part, this idea has arisen because the RIPK1 kinase
inhibitor, necrostatin, blocks necroptosis, and therefore, RIPK1
kinase activity and necroptosis have become synonymous. A
requirement for RIPK1 in necroptosis is suggested in the situa-
tion of the embryonic lethality of Casp8/ mice at embryonic
stage E10.5 because loss of Ripk1, like loss of Ripk3, prevents
this lethality. However, the Ripk1/ mouse shows that RIPK1
is not a universal requirement for necroptosis; if it were, then
Ripk1/Casp8/ mice would be completely defective in both
apoptotic and necroptotic pathways and phenocopy the viable1184 Cell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc.Ripk3/Casp8/ mice. However, com-
bined deletion of Casp8 and Ripk3 is
required to protect Ripk1/ mice, sug-
gesting that RIPK3-dependent necrop-
totic cell death can be activated in a
RIPK1-independent manner. The fact
that theRipk1/Mlkl/mice phenocopy
the Ripk1/Ripk3/ mice provides
further support for the idea that there is
physiological RIPK1-independent nec-
roptosis. Such RIPK1-independent nec-
roptosis is consistent with reports that
oligomerization and activation of RIPK3
may be driven by spontaneously high
RIPK3 levels or by another RHIM-con-
taining protein such as DAI or TRIF (Feok-
tistova et al., 2011; Moujalled et al., 2013;
Upton et al., 2010).Counterintuitively keratinocyte hyperplasia is an excellent
marker of excessive cell death in the skin as seen in the
epidermal keratinocyte-specific knockouts (EKO): cFlipEKO,
IkbkbEKO, FaddEKO,Casp8EKO, and Sharpin mutantmice (Bonnet
et al., 2011; Gerlach et al., 2011; Panayotova-Dimitrova et al.,
2013; Pasparakis et al., 2002). Ripk1/ mice have a similar
skin phenotype to these mice. Not only are MLKL and RIPK3
upregulated in the skin of Ripk1/ mice, but cFLIP is as well.
Combined upregulation of these necroptotic effectors and the
caspase-8 inhibitor cFLIP strongly suggests that Ripk1/ skin
cells are dying a necroptotic cell death, and this conclusion is
reinforced by the fact that the Ripk1/ skin phenotype is largely
prevented by loss of Ripk3 orMlkl, but not Casp8. Clearly, how-
ever, this necroptotic cell death is caused by loss of, and is not
dependent upon, RIPK1.
Loss of RIPK3 prevents the early embryonic lethality observed
in caspase-8 knockout mice (Kaiser et al., 2011; Oberst et al.,
2011), suggesting that loss of caspase-8 results in unchecked
RIPK3-dependent necroptosis. Although RIPK3 and caspase-8
are best known as cell death mediators, both have emerged as
direct regulators of the inflammasome and other inflammatory
signaling pathways (Kang et al., 2013; Vince et al., 2012). There-
fore, an alternative explanation for the E10.5 lethality is that
absence of caspase-8 leads to an increase in RIPK3-dependent
inflammatory cytokine production and death. The late lethality of
Ripk1 knockout mice has facilitated delineation of the relative
importance of these two functions because Ripk1/Ripk3/
mice have significantly less death and inflammation, whereas
the Ripk1/Myd88/ mice have reduced inflammation but
not dramatically reduced cell death. Further support for the
idea that necroptosis can be a driver of lethal inflammation
comes from the fact that Ripk1/Mlkl/ and Ripk1/Ripk3/
mice phenocopy each other with dramatically reduced inflam-
mation. MLKL functions downstream of RIPK3 in the necroptotic
pathway (Moujalled et al., 2013; Murphy et al., 2013; Sun et al.,
2012; Zhao et al., 2012) and may be a direct necroptosis effector
(Chen et al., 2014). Although MLKL may have a role in cytokine
production mediated by the inflammasome in the absence of
caspase-8 (Kang et al., 2013), it does not in response to Smac
mimetics (Wong et al., 2014) or a TLR ligand (Figure S5C).
Although Ripk1/ FLDMs showed RIPK3-dependent sponta-
neous activation of the inflammasome, it was at very low levels
compared to a conventional NLRP3 inflammasome stimulus
such as ATP. Furthermore, the systemic inflammation in the
Ripk1/ mice was not associated with markers of inflamma-
some activation. Taken together, we believe our data favor the
interpretation that necroptosis induces inflammation.
An outstanding question in the field is the nature of necroptotic
DAMPs (Kaczmarek et al., 2013). Because the Ripk1/ inflam-
matory phenotype is rampant before birth, in a sterile embryonic
environment, the DAMPs must be endogenous in origin. We
observed high numbers of apoptotic cells throughout the
Ripk1/ embryos, and contents from these uncleared cells
could feasibly generate DAMPs. However, we do not favor this
hypothesis because compound Ripk1/Casp8/ mice are
not protected from inflammation. We favor the hypothesis that
RIPK1-independent necroptotic cell death is the source of
DAMPs because both Ripk1/Ripk3/ and Ripk1/Mlkl/
are protected from the lethal inflammatory disease. HMGB1 is
released from necroptotic cells in vitro and has a role in certain
in vivo inflammation models (Scaffidi et al., 2002), suggesting
that it is a necroptotic DAMP. However, we did not observe
release of HMGB1 into plasma above control levels. Two other
DAMPs that have been associated with necroptosis, IL-1a and
IL-33 (Kaczmarek et al., 2013), were detected in the plasma of
Ripk1/mice. IL-33 was expressed at high levels in the intestine
and skin of Ripk1/. Furthermore, IL-33 was detected in a pro-
cessed form that corresponded to a previously reported neutro-
phil cleaved bioactive form (Lefranc¸ais et al., 2012). IL-1a is not
released during apoptosis (Cohen et al., 2010), and IL-33 was
suggested to be cleaved to a nonactive form (p25 and p10)
during apoptosis by caspase-3 (Lu¨thi et al., 2009). Combined
with the fact that IL-33 release into the plasma of the Ripk1/neonates is prevented by the Ripk3/ and Mlkl/, but not the
Casp8/ cross, this strongly suggests that IL-1a and IL-33
are in vivo necroptotic DAMPs in Ripk1/ mice. Furthermore,
becauseMyd88/mice are defective in IL-33 and IL-1a -medi-
ated inflammatory signaling and Myd88 deficiency extends the
survival of Ripk1/ mice, we conclude that these necroptotic
DAMPs play a major role in the Ripk1/ lethal systemic
inflammation.
Our findings reveal an essential physiological role for RIPK1
in immune homeostasis and emergency hematopoiesis.
Remarkably, direct regulation of TNFR1 by RIPK1 is not impor-
tant to prevent inflammation or cell death in the embryo, except
in a tissue-specific manner. RIPK1 is required for TNF-induced
necroptosis at E10.5; however, surprisingly, in later stages of
embryogenesis, RIPK1 plays an essential role in inhibiting nec-
roptosis. The fact that the Ripk1/Mlkl/ mice phenocopy the
Ripk1/Ripk3/ mice provides the strongest evidence so far
that, in the context of inflammatory signaling, the role of RIPK3
in generating necroptotic DAMPs is at least as important as its
direct role in promoting inflammatory cytokine production. We
therefore propose that loss of RIPK1 inhibition of RIPK3/MLKL-
dependent necroptosis promotes the production and release of
necroptotic DAMPs such as IL-1a and IL-33, revealing a key
function for RIPK1 in limiting, not only promoting, inflammation.
EXPERIMENTAL PROCEDURES
Mice
All mice were backcrossed to C57BL/6J mice for >10 generations or gener-
ated on a C57BL/6J background. Mlkl/ mice were generated as described
(Murphy et al., 2013). Mice obtained by Caesarean section at E19.5 or a few
hours after natural birth were designated P0. Pregnant mice were prepared
for Caesarean delivery by progesterone injection at E17.5 and E18.5. The rele-
vant Animal Ethics Committee approved all experiments.
Histology and Immunofluorescence
Embryos were fixed in 10% neutral buffered formalin, paraffin embedded, and
sectioned for routine histology staining (H&E). For skin immunofluorescence,
paraffin sections were dewaxed, subjected to heat-induced epitope retrieval
(HIER) with citrate buffer, blocked in 3% goat serum, permeabilized with
0.3% Triton X-100, and stained with keratin 6 (Covance), keratin 14, and
goat anti-rabbit alexa-594 (Invitrogen) antibodies. Nuclei were visualized using
Hoechst (Invitrogen). For tissue immunohistochemistry, sections were dew-
axed and subjected to antigen retrieval in trypsin buffer (F4/80) or HIER with
citrate buffer (CD45, CC3) and stained with the following antibodies: anti-
CC3 (Cell Signaling Technology 9661), anti-CD45 (BD), anti-F4/80 (generated
in-house), goat anti-rabbit biotinylated, and goat anti-rat biotinylated anti-
bodies (Vector Laboratories). Images were taken using a DP72 microscope
and cellSens Standard software (Olympus).
Cytokine Bioplex Assay
Cytokines were measured by Bioplex Pro mouse cytokine 23-plex assay (Bio-
Rad) according to manufacturer’s instructions. Where a value was above or
below the reference range, it was assigned the value of the highest or lowest
standard, respectively. Lysates were made by homogenizing organs in ice-
cold protein DISC lysis buffer followed by protein level normalization using a
BCA assay (Thermo Scientific). Skin samples were obtained from mice deliv-
ered by Caesarean at E20.5.
Chimeras
For hematopoietic reconstitution experiments, congenic C57BL/6.SJL (Ptprca
Pep3b [Ly5.1]) mice were reconstituted with 106 Ptprcb Pep3a (Ly5.2) fetal liver
cells from E13.5 embryos. Serial transplants: 0.2–5 3 106 bone marrow cellsCell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc. 1185
from primary donors were reconstituted into secondary irradiated Ly5.1 recip-
ient mice. Competitive transplants: Ly5.1 mice were reconstituted with 106
fetal liver cells from Ly5.1/5.2 and knockout Ly5.2 mice at a 1:1 ratio. TNF-
neutralization: mice were injected with 200 mg of anti-TNF (XT22) or isotype
control three times per week for 2 weeks and then weekly for 6 weeks. Recip-
ient mice received two 5.5-Gy doses of irradiation given 3 hr apart.
Progenitor Cell Analysis
Clonal cultures of hematopoietic cells were performed as described (Croker
et al., 2004). For some experiments, sorted lineage cKit+ E18.5 liver cells
were cultured in 100 ng/ml SCF + 10 ng/ml IL-3 + 4U/ml EPO with PBS,
10 ng/ml TNF, or 200 ng/ml Fc-FasL for 24 hr. To analyze progenitor viability,
lineage cKit+ cells were monitored by flow cytometry with PI.
Immunoblotting
Organ lysates were made by homogenizing whole intestine or dorsal skin from
P0 mice in ice-cold DISC lysis buffer containing cOmplete protease inhibitor
cocktail (Roche), 20 mMMG132, 5 mMN-ethylmaleimide, 10 mM sodium fluo-
ride, 5 mM b-glycerophosphate, 2 mM sodium pyrophosphate, 2 mM sodium
pervanadate, and 1 mM sodium molybdate. Insoluble component was spun
down, and supernatants were quantified with a BCA assay (Thermo Scientific).
Supernatants were boiled with SDS reducing sample buffer. Plasma samples
were diluted with PBS and boiled with SDS reducing sample buffer. Organ
lysates and plasma samples were run on 4%–12% Bis-Tris gels (Invitrogen).
Fetal liver lineage cKit+ cells were lysed as previously described (Croker
et al., 2004). Membranes were probed with CC3 or -8 (Cell Signaling Technol-
ogy 9661 and 8592, respectively), IL1a (Abcam ab9724), IL33 (R&D Systems
AF3626), IL1b (R&D Systems AF-401-NA), caspase-1 (Santa Cruz sc-514 or
clone 4G8; gift from Lorraine O’Reilly), MLKL (clone 3H1 described in Murphy
et al. [2013]), RIPK1 (BD Transduction 610458), RIPK3 (Axxora PSC-2283-
c100), cFLIP (ProScience XA-1008), HMGB1 (Abcam ab18256), or b-actin
(Sigma-Aldrich A-1978) antibodies.
Hematology and Flow Cytometry
Automated cell counts were performed on blood collected from the retro-
orbital plexus intoMicrotainer tubes containing EDTA (Sarstedt) using an Advia
2120 hematological analyzer (Siemens). For further analysis, blood smears
were performed and assessed following May-Gru¨nwald Giemsa staining.
Flow cytometric analysis of hematopoietic cells was performed on a BD
Biosciences LSRFortessa cell analyzer and analyzed using FlowJo software
(Treestar). Ly5.1 and Ly5.2 expression determined the contribution of donor
and recipient cells. Blood glucose was quantified using an Accu-Chek Per-
forma (Roche) glucometer.
Bone-Marrow-Derived Macrophages and Fetal-Liver-Derived
Macrophages
Macrophages were generated by culturing cell suspensions generated from
bone marrow (for bone-marrow-derived macrophages, BMDMs) or E14.5 fetal
livers (for fetal-liver-derivedmacrophages, FLDM) and differentiated for 7 days
in M-CSF L929 conditioned media. For cell death assays, FLDMs were treated
with recombinant human Fc-TNF and QVD (SM Biochemicals LLC) as indi-
cated for 24 hr and then subjected to cell death analysis by flow cytometry
quantification of PI uptake using a FACSCalibur (BD Biosciences). For the
inflammasome assays, FLDMs were plated at 50–100,000 cells per well in
a 96 well plate and stimulated with LPS (20 ng/ml) for 6–8 hr followed
by ±5 mM ATP for 40–60 min. Lysates and supernatants were analyzed by
western blotting. Supernatants were analyzed by ELISA (IL-1b, R&D Systems).
Controls for caspase-1 and IL-1b detection in plasma and organs using west-
ern blotting were generated using BMDMs treated as above or pretreated with
LPS for 2 hr followed by Smacmimetic treatment for 6 hr (GT12911, TetraLogic
Pharmaceuticals). For Figure S6C, BMDMsof indicated genotypes (n = 3) were
treated with LPS (20 ng/ml) for 9 hr, and IL-6 levels in supernatants were
analyzed by ELISA (eBioscience).
Statistics
Unless otherwise specified, data are presented as mean + 1 SEM. Compari-
sons were performed with a Student’s t test.1186 Cell 157, 1175–1188, May 22, 2014 ª2014 Elsevier Inc.SUPPLEMENTAL INFORMATION
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